BillionToOne, Inc. (BLLN) vs Oruka Therapeutics, Inc. (ORKA)
A side-by-side comparison of BillionToOne, Inc. and Oruka Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLLN
BillionToOne, Inc.
$100.80HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
ORKA
Oruka Therapeutics, Inc.
$79.74HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — BLLN vs ORKA
growth of $100 · dividends reinvested · last 1yBLLN +0.1% (+0.1%/yr)ORKA +207.9% (+207.9%/yr)ORKA compounded faster over this window
BLLN ORKA
BLLN vs ORKA: by the numbers
- •ORKA is the larger company ($4.81B vs $4.64B market cap).
- •BLLN is profitable (8.43% net margin) while ORKA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BLLN | ORKA |
|---|---|---|
| P/E ratio | 162.55 | N/A |
| Forward P/E | 126.91 | N/A |
| P/S ratio | 11.67 | N/A |
| P/B ratio | 8.64 | 4.33 |
| EV / EBITDA | 76.11 | N/A |
| FCF yield | 0.72% | N/A |
Profitability
| Metric | BLLN | ORKA |
|---|---|---|
| Gross margin | 71.27% | 0.00% |
| Operating margin | 10.90% | 0.00% |
| Net margin | 8.43% | 0.00% |
| ROE | 6.24% | -11.92% |
| ROIC | 6.39% | -13.88% |
Growth (annualized)
| Metric | BLLN | ORKA |
|---|---|---|
| Total return CAGR (5Y) | N/A | 32.76% |
Frequently asked
- Is BLLN or ORKA more profitable?
- BLLN runs the higher net margin — BLLN at 8.43% versus ORKA at 0.00%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.